Connect with us

business

Is the Cannabis Recession Here? – Cannabis | Weed | Marijuana

Published

on


Is the cannabis recession here? According to a new study exclusive to Forbes, cannabis industry employment has declined, a first in history.

The 2% reduction comes after six years of double-digit growth. It can hardly be considered a sign of a cannabis recession. However, broader economic trends point to a recession, even a depression, on the horizon.

And the cannabis industry will not be immune to it. In fact, we may already be witnessing signs of the cannabis recession.

Is the Cannabis Recession Here?

Is the Cannabis Recession Here?
AP Photo/Jeff Chiu

According to the Forbes study, the cannabis recession is less about employment numbers and more about lack of capital.

Venture capital funding is down 96% year over year. In both America and Canada, banks have also been no help.

For the first two years of the Biden presidency, venture capital was kept alive by beliefs that the Democrat-controlled White House and Congress would legalize cannabis. Or, at the very least, pass some cannabis banking regulation.

But when 2022 ended without either, investors started putting their money elsewhere. Cannabis stocks have dropped 50% to 70% year over year. 

We’ve covered the covid-inspired cannabis bubble before. That’s where the industry saw an artificial boom fueled by the “end of the world” mentality and the fact millions of people were under a sort of “public health” house arrest.

So people turned to alcohol and other drugs, gambling or adult content to cope with the stress or just simple boredom. Fortunately, many consumers chose benign, nontoxic cannabis for recreation.

But that boom is now over. Coupled with the lack of reform in the United States, the cannabis recession is here. Investors are dropping off, and revenues are down.

Budtenders and trimmers are losing work not because of performance but because the company needs more financial capital.

The cannabis industry is cash-strapped. 

The Numbers

cannabis recession

The Forbes study found that while most cannabis jobs are low-paying, there are enough to create massive economic value. 

U.S. medical and recreational dispensaries accounted for $26.1 billion in legal sales. 31% of cannabis jobs are in farming, with retail stores making up 23%. The remaining work is in ancillary work, including marketing, distribution, legal services, manufacturing, and processing.

California experienced the most significant drop in employment – 13% from last year. That’s 12,600 fewer cannabis jobs than available last year.

This translated into an 8.2% drop in sales, the first time since the state legalized recreational cannabis in 2018. 

However, California’s robust “illicit” legacy market – estimated to be 50% of the market – skew these numbers slightly. And because of California’s lack of legal stores and overproduction by legal growers, a price war has launched, resulting in wholesale cannabis prices dropping by 50%.

Colorado is down, too, with a drop in 28% of its cannabis workforce, or 10,481 workers. The state’s legal sales dropped from $2.2 billion in 2021 to $1.8 billion in 2022.

Oregon’s cannabis workforce is down by 21%. 

However, we can explain many of these declines by neighboring states that have legalized. Consumers no longer have to go to Colorado or Oregon for legal weed.

And the numbers reflect this. Missouri just legalized and has hundreds of new retail stores. The same goes for Michigan, where cannabis jobs and revenue are growing.

Florida, too, which has the country’s largest medical cannabis market, saw 3,000 new jobs added.

But one wonders how much of this is sustainable in the long term. When the dust settles, will these new legal states maintain their current level of employment? Or will the cannabis recession come for them too?

Cannabis Recession In Canada?

cannabis recession

Has the cannabis recession come to Canada’s legal industry? The Forbes study doesn’t address the Canadian market, but looking at the latest headlines tells the story.

For example, Canadian pot stocks have taken a beating.

Tilray’s stock fell nearly 60% in 2022. That’s down 93% from its all-time high. Considered an industry leader, Canopy has had a year-over-year decline of around 70%.

Canopy’s third quarter in 2022 saw the following:

  • $122 million decline in revenue
  • $1.83 billion operating expenses (up nearly 1000%)
  • Minus $2 billion in net income
  • Minus $5.38 in earnings per share, down from a positive number.

2022 also saw Aurora Cannabis decline by almost 80%. If you’d invested $1000 into Aurora in 2013 and cashed out right after legalization in 2018, you would have been $500,000 richer.

If you cashed out now? You’d have about $200.

Even ETFs have dropped. Marijuana Life Sciences, for example, saw a 46% decline in 2022.

Meanwhile, the Cannabis Council of Canada (C3) requests “immediate financial relief” from the federal government. They say excessive regulations, taxes, provincial distributor monopolies, and the general “stigma” of the industry have led to what is essentially a cannabis recession.

Is the cannabis recession here? It sure looks like it. 

Will We See a Cannabis Recession in 2023?

cannabis recession

The economy is heading to a recession because of the Federal Reserve in the United States. Interest rates are market-based prices for the money itself. “Setting” an interest rate like it were a public policy is engaging in price controls.

And price controls lead to surpluses and shortages. In this sense, an oversupply of money. 

Since the Dot Com crash at the beginning of the millennium, the Fed has forced interest rates down. This fueled the housing bubble, which the Fed reinflated as an “everything” bubble.

And then covid happened, and governments started handing out money as if it was the money itself that was important.

But you can’t eat pieces of paper. It’s not the money that’s vital, but its purchasing power. And since the creation of the Federal Reserve, the purchasing power of the American dollar has declined year after year with no end in sight.

An economic depression may result in a covid-like demand for cannabis. But it remains to be seen how effective this will be at boosting America’s cannabis industry.

As for Canada, like most of its economic issues, the problem stems from too much intervention from federal and provincial governments. 

For farmers and operators to survive a cannabis recession, the government simply needs to get out of the way.





Source link

business

Marijuana rescheduling leaves regulators and sellers cautiously optimistic

Published

on

By



A move by the Biden Administration to change how marijuana is treated by federal authorities was met with cautious approval by Massachusetts state regulators, cannabis sellers, and national marijuana advocates alike.

The Drug Enforcement Agency will drop marijuana from the list of banned substances found under Schedule I of the Controlled Substances Act, where it currently sits alongside heroin and LSD. It will instead move it to Schedule III, among the likes of Tylenol with codeine and anabolic steroids. This follows the recommendation of the Department of Health and Human Services

“Rescheduling cannabis is a monumental step forward for the federal government, one that can open new avenues to research, medical use, and banking for the regulated industries states like Massachusetts have built across the country,” said Ava Callender Concepcion, the acting chair of the Bay State’s Cannabis Control Commission.

Read the rest of this story on BostonHerald.com.



Source link

Continue Reading

business

Thailand Considers Relisting Cannabis as a Narcotic

Published

on

By


The Thai government is contemplating the relisting of cannabis as a narcotic due to concerns over its recreational use and potential societal harms. This reconsideration comes after cannabis was decriminalized in June 2022, which led to a surge in its availability and use.

Cannabis Conundrum: Thailand Reconsiders Legal Status Amidst Rising Concerns

The recent decriminalization of cannabis in Thailand has ignited a complex debate over its legal status and societal impact. While the policy aimed to boost the medical marijuana industry and provide economic opportunities, the unintended rise in recreational use has sparked discussions about a potential reclassification.

Public Health Minister Anutin Charnvirakul, a key advocate for the decriminalization, emphasized that the policy was intended to promote medical use, not recreational. However, the current legal framework lacks clear regulations governing recreational use, leading to widespread availability and potential misuse.

The Bhumjaithai Party, led by Anutin, initially pushed for the delisting of cannabis to benefit the medical industry and provide economic opportunities for Thai citizens. However, the subsequent surge in recreational use, particularly among youths, has raised concerns about potential health and social consequences.

Opposition parties have criticized the government for inadequate regulations and are advocating for cannabis to be relisted as a narcotic under the Narcotics Act. They argue that the current situation exposes young people to potential harm and lacks sufficient safeguards.

A recent poll revealed that a majority of Thais support stricter regulations on cannabis use. Concerns have been raised about the potential impact on public health, particularly regarding mental health issues and addiction, especially among youths. Additionally, there are worries about the potential for increased crime and social disorder.

The government now faces the challenge of balancing the economic benefits of a burgeoning cannabis industry with the need to protect public health and safety. Finding a solution that addresses the concerns of both advocates and critics will be crucial in determining the future of cannabis in Thailand

Why It Matters

Thailand’s shift in cannabis policy has garnered international attention, serving as a case study for the complexities of drug policy reform. The potential reclassification of cannabis underscores the challenges of balancing economic opportunities with public health and safety considerations. The outcome of this debate will have significant implications for Thailand’s legal landscape, public health policies, and the future of its cannabis industry.

Potential Implications of Relisting Cannabis as a Narcotic

If cannabis is relisted as a narcotic, it could lead to stricter regulations on its cultivation, distribution, and use. This may impact the growth of the medical marijuana industry and limit access for patients who rely on cannabis for therapeutic purposes. Additionally, it could result in increased criminal penalties for possession and use, potentially leading to a rise in incarceration rates.

Alternatively, if the government opts to maintain the decriminalized status, it will need to implement robust regulations and public health campaigns to mitigate the risks associated with recreational use. This includes age restrictions, educational initiatives, and support systems for individuals struggling with cannabis dependence.

The Bigger Picture

The debate surrounding cannabis legalization and regulation is a global phenomenon, with countries around the world grappling with similar challenges. The Thai government’s decision regarding cannabis will likely be influenced by international trends and best practices in drug policy reform. It is crucial to consider the experiences of other nations that have legalized or decriminalized cannabis, examining both the successes and challenges they have encountered.

Source: Thai PBS World



Source link

Continue Reading

banking

“A big deal”: What the feds’ move to reclassify marijuana means for Colorado cannabis

Published

on

By



Cannabis advocates in Colorado cheered the Biden Administration’s reported move to reclassify marijuana and said the decision likely would reduce businesses’ tax burden significantly.

Industry leaders cautioned that such a move — if finalized — would not resolve some major challenges facing the industry, such as limited access to banking. But they pointed to the symbolic importance of preparations by the U.S. Drug Enforcement Administration to downgrade the substance’s drug classification.

A man pours cannabis into rolling papers as he prepares to roll a joint the Mile High 420 Festival in Civic Center Park in Denver, April 20, 2024. (Photo by Kevin Mohatt/Special to The Denver Post)

Read the rest of this story on DenverPost.com.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media